Skip to content
MedsAcross

Brand family

Brinsupri

Brensocatib · Insmed
United States
Presentations
2
Markets
1

Brinsupri is a brand of Brensocatib marketed by Insmed, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Brensocatib
Brand owner
Insmed
Registered in
United States
Strengths and forms
10 mg tablet, 25 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Brinsupri 10 mg tabletOralInsmedUS FDAAvailable on request
Brinsupri 25 mg tabletOralInsmedUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Brinsupri

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.